Sign In
Buy CNMD
$35.16
+0.0300 (+0.0854%)
At Close: Jun 05, 2026
Here's Why You Should Retain CONMED Stock in Your Portfolio Now
11:56am, Tuesday, 10'th Mar 2026
CNMD's growth rests on AirSeal, Buffalo Filter and BioBrace as supply chains normalize, even as tariffs and a GI exit pressure EPS.
Conmed (CNMD) Up 22.9% Since Last Earnings Report: Can It Continue?
12:30pm, Friday, 27'th Feb 2026
Conmed (CNMD) reported earnings 30 days ago. What's next for the stock?
Here's Why You Should Retain CONMED Stock in Your Portfolio for Now
02:01pm, Tuesday, 10'th Feb 2026
CNMD's growth rests on AirSeal, Buffalo Filter and BioBrace as supply chains normalize, even as tariffs and a GI exit pressure EPS.
CONMED Corporation (NYSE:CNMD) Receives Consensus Recommendation of “Reduce” from Analysts
03:00am, Sunday, 01'st Feb 2026
Shares of CONMED Corporation (NYSE: CNMD - Get Free Report) have been assigned a consensus recommendation of "Reduce" from the eight ratings firms that are currently covering the firm, Marketbeat Rati
CONMED Q4 Earnings Call Highlights
05:12am, Friday, 30'th Jan 2026
CONMED (NYSE: CNMD) reported fourth-quarter fiscal 2025 sales of $373.2 million, representing a 7.9% year-over-year increase as reported and 7.1% growth in constant currency, as management emphasized
CONMED Stock Up Post Q4 Earnings and Revenue Beat, Gross Margin Up
01:20pm, Thursday, 29'th Jan 2026
CNMD posts strong fourth-quarter 2025 results with EPS and revenue beat, driven by surgical growth and improved gross margin.
Compared to Estimates, Conmed (CNMD) Q4 Earnings: A Look at Key Metrics
08:01pm, Wednesday, 28'th Jan 2026
Although the revenue and EPS for Conmed (CNMD) give a sense of how its business performed in the quarter ended December 2025, it might be worth considering how some key metrics compare with Wall Stree
CONMED Corporation (CNMD) Q4 2025 Earnings Call Transcript
07:22pm, Wednesday, 28'th Jan 2026
CONMED Corporation (CNMD) Q4 2025 Earnings Call Transcript
CONMED Corporation Announces Fourth Quarter and Full-Year 2025 Financial Results
04:05pm, Wednesday, 28'th Jan 2026
LARGO, Fla.--(BUSINESS WIRE)--CONMED Corporation (NYSE: CNMD) today announced financial results for the fourth quarter and full-year ended December 31, 2025. Fourth Quarter 2025 Highlights Sales of $3
CONMED Corporation (CNMD) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
10:16pm, Monday, 12'th Jan 2026
CONMED Corporation (CNMD) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
CONMED Corporation Announces Chief Financial Officer Transition
04:55pm, Thursday, 08'th Jan 2026
LARGO, Fla.--(BUSINESS WIRE)--CONMED Corporation (NYSE: CNMD) today announced the departure of Todd Garner from his role as Chief Financial Officer effective March 15, 2026. To ensure a smooth and ord
CONMED Corporation (NYSE:CNMD) Receives Average Recommendation of “Reduce” from Analysts
01:44am, Wednesday, 07'th Jan 2026
CONMED Corporation (NYSE: CNMD - Get Free Report) has earned an average rating of "Reduce" from the eight analysts that are presently covering the company, Marketbeat Ratings reports. Two analysts hav
CONMED Corporation to Present at the 44th Annual J.P. Morgan Healthcare Conference
04:10pm, Monday, 05'th Jan 2026
LARGO, Fla.--(BUSINESS WIRE)--CONMED Corporation (NYSE: CNMD) today announced that Patrick J. Beyer, President and Chief Executive Officer, and Todd W. Garner, Executive Vice President and Chief Finan
CONMED Corporation to Announce Fourth Quarter 2025 Financial Results on January 28, 2026
04:05pm, Monday, 05'th Jan 2026
LARGO, Fla.--(BUSINESS WIRE)--CONMED Corporation (NYSE: CNMD) today announced that it will report financial results for the fourth quarter 2025 after the market close on Wednesday, January 28, 2026. T
Here's Why You Should Retain CONMED Stock in Your Portfolio Now
08:35am, Wednesday, 31'st Dec 2025
CONMED gains momentum from high-margin platforms and supply-chain recovery, even as tariffs and dV5 adoption weigh on near-term margins.
